Concurrent Session Abstracts J: Comparative Effectiveness in Practice and Policy

Wednesday, October 22, 2008: 8:00 AM
Grand Ballroom AB (Hyatt Regency Penns Landing)
Discussant:
Daniel Polsky
Session Chair:
Allison B. Rosen, MD, ScD
8:00 AM
THE IMPACT OF BASELINE HEALTH STATUS ON THE PRIORITIZATION OF INTENSIVE CONTROL OF GLUCOSE AND BLOOD PRESSURE LEVELS IN ELDERLY PATIENTS WITH DIABETES
Elbert S. Huang, MD, MPH, Aaron N. Winn, MPP, Priya M. John, MPH, Marshall H. Chin, MD, MPH and David O. Meltzer, MD, PhD, University of Chicago, Chicago, IL
8:15 AM
ESTIMATING THE IMPACT OF VALUE-BASED INSURANCE DESIGN ON U.S. LIFE EXPECTANCY, HEALTH CARE COSTS, AND INCREMENTAL COSTS OF PROVIDING UNIVERSAL HEALTH INSURANCE
R. Scott Braithwaite, MD, MSc, FACP1, Cynthia Omokaro, MPH1, Amy C. Justice, MD, PhD2, Kimberly Nucifora, MS2 and Mark S. Roberts, MD, MPP3, (1)General Internal Medicine, West Haven, CT, (2)Yale University / VA Connecticut Healthcare Center, West Haven, CT, (3)University of Pittsburgh School of Medicine, Pittsburgh, PA
8:30 AM
USING VALUE OF INFORMATION ANALYSIS TO ESTABLISH THE POTENTIAL BENEFIT OF FURTHER COMPARATIVE EFFECTIVENESS RESEARCH: THE CASE OF CLOPIDOGREL IN THE UK
Wolf Rogowski, PhD1, Stephen Palmer, MSc2, Jane Burch, PhD3 and Nerys Woolacott, PhD2, (1)Helmholtz Zentrum München. German Research Center for Environmental Health (GmbH), Neuherberg, Germany, (2)University of York, York, United Kingdom, (3)Centre for Reviews and Dissemination, University of York, York, United Kingdom
8:45 AM
DO TECHNOLOGY EVALUATIONS BASED ON EVIDENCE FROM CONDITIONAL FUNDING LEAD TO AN INCREASE IN POLICY FORMATION?: FINDINGS FROM, AND IMPLICATIONS OF, ONTARIO'S EVIDENCE-BASED HTA PROCESS
Ron Goeree, MA1, Daria J. O'Reilly, PhD, MSc1, Jean-Eric Tarride, PhD, MA1, Feng Xie1, James M. Bowen, BScPhm, MSc1, Gord Blackhouse, MSc.2 and Robert Hopkins, MA1, (1)McMaster University, Hamilton, ON, Canada, (2)McMaster Unviersity, Hamilton, ON, Canada